Contact Points
Upland, California 91786
United States
The NINDS Viral Production Core Facility produces viral vectors for NIH laboratories. One technique used for purifying lentiviral vectors is ultracentrifugation at a relative centrifugal force, RCF, of 85,000 x g.The SW 32 rotor is capable of producing this RCF. Lentiviral vectors are ~40% of the viral vectors produced by the NINDS Viral Production Core Facility so increasing the throughput of lentiviral vector production will make the core more efficient in proccessing viral vectors.
Interested parties may identify in writing their interest and capability in response to this requirement. Responses to this notice shall contain sufficient information to establish the interested parties’ bona-fide capabilities for fulfilling the requirement and include: unit price, list price, shipping and handling costs, the delivery period after contract award, the prompt payment discount terms, the F.O.B. Point (Destination or Origin), the Dun & Bradstreet Number (DUNS), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.
All responses must be received by closing date and must reference the announcement. Responses may be submitted electronically to the attention of the contract specialist. Fax responses will not be accepted.
All responsible sources may submit a bid, proposal, or quotation which shall be considered by the agency.